[go: up one dir, main page]

AR133167A1 - Macrociclos para el tratamiento de enfermedad autoinmunitaria - Google Patents

Macrociclos para el tratamiento de enfermedad autoinmunitaria

Info

Publication number
AR133167A1
AR133167A1 ARP240101740A ARP240101740A AR133167A1 AR 133167 A1 AR133167 A1 AR 133167A1 AR P240101740 A ARP240101740 A AR P240101740A AR P240101740 A ARP240101740 A AR P240101740A AR 133167 A1 AR133167 A1 AR 133167A1
Authority
AR
Argentina
Prior art keywords
macrocycles
treatment
autoimmune disease
compounds
formula
Prior art date
Application number
ARP240101740A
Other languages
English (en)
Inventor
Min Jiang
Buyu Kou
Haixia Liu
Hong Shen
Yao Wu
Zhiwei Zhang
Wei Zhu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR133167A1 publication Critical patent/AR133167A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula (I-2), en los que R¹ a R³, Q¹, Q², A¹ a A⁷ y M¹ son como se describe en el presente documento, y la sal farmacéuticamente aceptable de los mismos, y composiciones que incluyen los compuestos y los procedimientos de uso de los compuestos.
ARP240101740A 2023-07-07 2024-07-04 Macrociclos para el tratamiento de enfermedad autoinmunitaria AR133167A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2023106401 2023-07-07

Publications (1)

Publication Number Publication Date
AR133167A1 true AR133167A1 (es) 2025-09-03

Family

ID=91898258

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240101740A AR133167A1 (es) 2023-07-07 2024-07-04 Macrociclos para el tratamiento de enfermedad autoinmunitaria

Country Status (3)

Country Link
AR (1) AR133167A1 (es)
TW (1) TW202517653A (es)
WO (1) WO2025012057A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120904077A (zh) * 2025-09-30 2025-11-07 安徽泽升科技股份有限公司 一种苯肼盐酸盐的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563081A (zh) 2016-04-07 2019-04-02 葛兰素史克知识产权开发有限公司 可用作蛋白调节剂的杂环酰胺类
US11358973B2 (en) * 2018-04-16 2022-06-14 Shenzhen Targetrx, Inc. Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity
SMT202400399T1 (it) * 2019-07-22 2024-11-15 Lupin Ltd Composti macrociclici come agonisti di sting e metodi e usi di questi
JP2025519430A (ja) * 2022-06-06 2025-06-26 エフ． ホフマン－ラ ロシュ アーゲー 自己免疫疾患の処置のためのインダゾール大環状分子

Also Published As

Publication number Publication date
WO2025012057A1 (en) 2025-01-16
TW202517653A (zh) 2025-05-01

Similar Documents

Publication Publication Date Title
AR126854A1 (es) Compuestos macrocíclicos para el tratamiento de cáncer
CO2022008997A2 (es) Compuestos tricíclicos sustituidos
CO2022010460A2 (es) Compuestos tricíclicos sustituidos
CO2025001184A2 (es) Compuestos macrocíclicos para el tratamiento de cáncer
CL2024004085A1 (es) Compuestos macrocíclicos inhibidores de kras, uso para tratar cáncer.
AR133266A1 (es) Macrociclos para el tratamiento de enfermedades autoinmunitarias
PE20230249A1 (es) Compuestos de heteroarilo biciclicos y usos de estos
CO2025010435A2 (es) Compuestos tricíclicos para el tratamiento de cáncer
UY38057A (es) Inhibidores de sarcómero cardíaco
AR132340A1 (es) Compuestos tricíclicos para el tratamiento de cáncer
AR133199A1 (es) Macrociclos bicíclicos para el tratamiento de enfermedades autoinmunitarias
CO2024011088A2 (es) Macrociclos de imidazol para el tratamiento de enfermedades autoinmunitarias
MX2022007171A (es) Compuestos cíclicos y métodos de uso de estos.
CL2021002621A1 (es) Compuestos de hexahidro-1h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria
UY39181A (es) COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE HIF2a Y SUS MÉTODOS DE USO
AR133167A1 (es) Macrociclos para el tratamiento de enfermedad autoinmunitaria
MX2025002817A (es) Compuestos para el tratamiento del cancer
CL2025000161A1 (es) Compuestos cíclicos y métodos de utilización de estos.
CO2022006942A2 (es) Compuestos de 1,8-naftiridin-2-ona para el tratamiento de una enfermedad autoinmunitaria
CO2022004391A2 (es) Derivados de 5-oxa-2–azaespiro[3.4]octano como agonistas de m4
EA202091481A1 (ru) Замещенные алкиниленовые соединения в качестве противораковых агентов
CL2024000791A1 (es) Compuestos de pirazolo[3,4-b]piridina para el tratamiento de enfermedades autoinmunitarias
DOP2024000096A (es) Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno
ECSP088237A (es) Derivados de quinolina y uso como agentes antitumor
AR133915A1 (es) Macrociclos para el tratamiento de enfermedades autoinmunitarias